The company issued guidance for Q3, sees EPS of $2.25-2.35, may not be comparable to $2.34 Capital IQ Consensus Estimate; sees Q3 revs of $570 mln vs. $550.75 mln Capital IQ Consensus Estimate. Co issues mixed guidance for FY13, sees EPS of $2.74-2.84 vs. $2.76 Capital IQ Consensus Estimate; sees FY13 revs of $1.41 bln vs. $1.38 bln Capital IQ Consensus Estimate.
The company concluded, "At present, we are focused on shipping for our peak Fall selling season, as well as integrating Vilebrequin's operations into our business. We are also off to a good start with our Spring '13 market showings to retailers."






